Our research presentations
This section lists selected presentations of our 22q research results for medical professionals and researchers.
To see presentations tailor-made for individuals with 22q11.2DS, their families and caregivers, or the general public, please go to our presentations page.
Research Presentations in 2022
The 12th Biennial International 22q11.2 Conference - Professional Meeting
June 29th to July 1st, 2022
- Lifetime Health Care Burden of Adults with 22q11.2 Deletion Syndrome
- How Adults with 22q11.2 Deletion Syndrome Fared in the COVID-19 Pandemic in Canada
- Adult Height, Deletion Extent and Short Stature in 22q11.2 Deletion Syndrome
- Hypothyroidism and Risk of Schizophrenia in Individuals with 22q11.2 Deletion Syndrome
- Reproductive Outcomes in Adults with 22q11.2 Deletion Syndrome
- Features of 22q11.2 Deletion Syndrome and Transition to Adult Care
- Nutrition-Related Issues and the Role of the Dietitian for Adults With 22q11.2 Deletion Syndrome
- Treatment of Schizophrenia in 22q11.2 Deletion Syndrome
- Influence of Rare and Common Genetic Variation on Dyslipidemia Risk in 22q11.2 Deletion Syndrome
Here are photos of Dr. Anne Bassett and Samantha D’Arcy’s presentations:
Schizophrenia Research Lunch & Learn
Centre for Addiction and Mental Health Toronto, ON, Canada June 6th, 2022
Dopamine 2022 Meeting
Montreal, QC, Canada May 24th, 2022 Common genetic and pathological drivers of dopamine dysfunction in neuropsychiatric disorders and neurogenerative diseases
Research Presentations in 2021
Ontario Cleft Lip Palate Speech Language Pathologist Annual Meeting
Invited Presentation (by Zoom) October 26th, 2021
American Society of Human Genetics (Virtual Conference)
October 18th to 22nd, 2021 Schizophrenia risk mediated by microRNA target genes in 22q11.2 deletion syndrome PrgmNr 2631 Ying S, Bassett AS.
International Symposium on Adult Congenital Heart Disease (Virtual Conference)
International Society for Adult Congenital Heart Disease October 13th, 2021 Incidence of infective endocarditis in adults with congenital heart disease and diagnosed 22q11.2 deletion syndrome Adonis Ng, Tracy Heung, Erwin Oechslin, Jessica Patzer, Anne Bassett [Abstract PDF] Infective endocarditis is a life-threatening infection of the bloodstream that settles inside the heart. Our team investigated whether or not the 22q11.2 deletion syndrome is an independent risk factor that increases the likelihood of infective endocarditis in adults with congenital heart disease and 22q compared to those without it. We compared the incidence amongst the consented patients at our clinic to the incidence in the general population. As expected, the incidence was much higher in patients at our clinic, suggesting that 22q should be treated as an independent risk factor for the development of infective endocarditis. Therefore, it’s an important step in advocating for extra attention being paid to these patients in the treatment and prophylaxis (or prevention) of endocarditis.
Adonis received the ISACHD Cardiac Care Professional Research Award for this work. Congratulations!
European Network EnGagE’s (Enhancing Psychiatric Genetic Counselling, Testing, and Training in Europe) educational lecture series
Invited Presentation (webinar by Zoom) September 30th, 2021
American Psychiatric Association Annual Meeting
May 1st to 3rd, 2021 Treatment resistant major depressive disorder, a rare form of 22q11.2 microdeletion and the efficacy of ketamine treatment. Kulikowski J, Martin L, Bassett AS.
Genomics of Brain Disorders (Virtual Conference)
Wellcome Genome Campus, UK April 14th to 16th, 2021 Schizophrenia risk mediated by microRNA target genes in 22q11.2 deletion syndrome. Ying S, Bassett AS.
Research Presentations in 2020
International Mental Health VIRTUAL Symposium
The Brain & Behavior Research Foundation October 30th, 2020 (pre-recorded by Zoom during COVID-19 pandemic)
Dr. Anne Bassett was the 2020 winner of the Lieber Prize for Outstanding Achievement in Schizophrenia Research from the Brain and Behavior Research Foundation. She described her work in a presentation entitled Identifying a Genetic Subtype of Schizophrenia That is Clinically Relevant for Patients and Families.
Research Presentations in 2019
22q11DS European Conference
Barcelona, Spain November 16th, 2019
At this annual congress about 22q for families and health professionals, Dr. Bassett presented a keynote presentation about optimizing outcomes for adults with 22q, met with families and participated in workshops.
The 43rdCanadian College of Medical Geneticists (CCMG) Annual Scientific Conference
Niagara Falls, ON, Canada June 23rd to 25th, 2019
22q11.2 deletion as a genetic model for multimorbidity in young adults Poster presentation by Tracy Heung
Predictors of all-cause mortality in adults with 22q11.2 deletion syndrome Poster presentation by Tracy Heung
European Human Genetics (ESHG) Conference
Gotenburg, Sweden June 15th to 18th, 2019
In this meeting for health professionals who work in human genetics, Dr. Anne Bassett presented on the burden of illness in patients with 22q, how this compares to the general public and how the patterns identified may in the future be used to identify genetic disorders within large populations.
22q11.2 deletion as a genetic model for multimorbidity in young adults. (Poster #P11) Poster presentation by Dr. Anne Bassett
Determination of disease-associated genes and gene-sets in Tetralogy of Fallot (Poster #P05) Poster presentation by one of our collaborators, Dr. Roozbeh Manshaei from the Ted Rogers Centre for Heart Research of the Hospital for Sick Children, Toronto.
Global Spine Congress
Toronto, ON, Canada May 15th to 18th, 2019
Jelle Homans, one of our collaborators and an orthopedics doctor from the Netherlands, gave a presentation on “The correlation between schizophrenia and scoliosis 22q11.2 Deletion Syndrome: Implications for further research?”
Research Presentations in 2018
The 90th Anniversary of the Biology Society of Chile - Joint Conference
The Biology Society of Chile
The Genetics Society of Chile
The Neuroscience Society of Chile
The Evolution Society of Chile
November 20th, 2018
Conference program (Spanish)
Dr. Erik Boot, our former Dalglish fellow who is specialized in intellectual disabilities, presented “22q11.2 deletion syndrome and Parkinson disease.” to the attendees of this conference.
The 3rd Scientific 22q11 Seminar for Families and Professionals
Center of Genetics and Genomics, Faculty of Medicine, Universidad del Desarrollo, Chile
November 16th, 2018
Dr. Erik Boot, our former Dalglish fellow who is specialized in intellectual disabilities, presented “22q11.2 deletion syndrome: A clinically identifiable model for early-onset Parkinson’s disease” to faculty members.
The 11th Biennial International 22q11.2 Conference - Professional Meeting
Whistler, BC, Canada
July 11th to 13th, 2018
Complete program with abstracts
The following list includes presentations by staff, students, and residents at both the Dalglish Family 22q Clinic and the Clinical Genetics Research Program (CGRP) at the Centre for Addiction and Mental Health (CAMH)
Bedside to Bench and Back Again - A Caregiver’s Tale (Invited Speaker; Abstract #1)
Medical Multimorbidity in Adults with 22q11.2DS (Abstract #92)
- Schizophrenia-Relevant Collections of Genes from the Rest of the Genome Contribute to Schizophrenia Expression in 22q11.2DS (Abstract #108)
Spencer van Mil
- Late Mortality in a Genetic Subtype of Tetralogy of Fallot (Abstract #32)
Endocrine Alterations in Adults with 22q11.2DS (Abstract #35)
- Parkinsonian Motor Features in Adults with 22q11.2DS (Abstract #82)
- Burden of Rare Coding Variants in the 22q11.2 Deletion Region is Associated with Educational Attainment and Schizophrenia Risk in Two General Population Cohorts (Abstract #72)
- Neurocognition and Adaptive Functioning in a Genetic High-Risk Model of Schizophrenia (Poster; Abstract #139)
- Predictors of All-Cause Mortality in Adults with 22q11.2DS (Abstract #91)
22q11.2 Society Website Update
- Personalized Medical Information Cards for Adults with 22q11.2DS (Abstract #93)
- Treatment of Schizophrenia in 22q11.2DS (Poster; Abstract #142)
- Characterizing Cooking Habits and Confidence in Food Skills in Adults with 22q11.2DS (Poster; Abstract #144)
Advanced Issues in Dual Diagnosis
Centre for Addiction and Mental health Dual Diagnosis Specialty Service Toronto March 21st, 2018
In this meeting for professionals working with patients with complex developmental and mental health issues, our Clinic fellow, Dr. Elemi Breetvelt, spoke about “22q11 Deletion Syndrome and the Criminal Justice System”. He provided insight on issues that may arise when law enforcement officers interact with adults with 22q.
Research Presentations in 2017
American Society of Human Genetics 2017 Meeting
Orlando, Florida, USA October 17th to 21st, 2017 Program number: 2683
Research presentations in 2016
Two-Day Workshop on 22q11.2 Deletion Syndrome
Hong Kong, China
December 1st to 2nd, 2016
On the first day, Dr. Bassett gave a lecture on brain and behaviour and adult complications as part of the programme on the clinical aspects of 22q11.2DS. On the second day, she talked about 22q11.2DS as a model for studying schizophrenia. She also played an important role in the discussions on how to set up a 22q11.2DS multidisciplinary clinic.
Schizophrenia Society of Canada National Conference
Halifax, Nova Scotia, Canada
October 27th, 2016
Dr. Bassett presented as the keynote speaker in this conference, delivering a talk about the clinical application of genetics for schizophrenia. She detailed clinical genetic testing and what the current standards of care are, and gave practical examples of how this relates to individuals with 22q.
American Society of Human Genetics 2016 Meeting
Vancouver, British Columbia, Canada
October 20th, 2016
Dr. Bassett presented a study that showed significantly higher prevalence of obesity in individuals with 22q11.2DS compared to the Canadian norm. Psychotropic medication and age were associated with higher obesity levels. (Program number: 3308T)
The 10th Biennial International 22q11.2 Conference
July 20th to 22nd, 2016
At this international 22q meeting, Dr. Bassett presented on rare copy number variations in 22q with and without schizophrenia. Dr. Boot presented on movement abnormalities in 22q. Clinic social worker Lisa Palmer presented on the “diagnostic odyssey” of patients with 22q and her work on attempting to better understand psychosexual knowledge in people with 22q. Past, current and future students and trainees Dr. Elemi Breetvelt, Ania Fiksinski, Sarah Voll and Nancy Butcher also presented on 22q!
Society of Biological Psychiatry Annual Scientific Convention
Atlanta, Georgia, USA
May 12th to 14th, 2016
At this annual meeting, Dr. Bassett presented along with Dr. Erik Boot and other 22q researchers on 22q as a valuable model for understanding schizophrenia, parkinson’s disease and other neuropsychiatric disorders. The presenters demonstrated how early changes to the brain can be identified in individuals with 22q, which may be able to help us find pre-diagnostic signs of disease and new targets for treatment
Research Presentations in 2015
Society of Biological Psychiatry 70th Annual Scientific Meeting
Toronto, Ontario, Canada
May 16th, 2015
Dr. Bassett presented at this annual meeting the results of a study which investigating the link between 22q11.2 deletions and risk for schizophrenia during pregnancy. Nancy Butcher also presented her results on use of clozapine in schizophrenia for individuals with 22q11.2DS.
72nd Annual Meeting & Pre-Conference Symposia of the American Cleft Palate-Craniofacial Association
Palm Springs, California, USA
April 20, 2015
Alongside our collaborator Donna McDonald-McGinn, Dr. Bassett presented the results of the practice guidelines for managing patients with 22q11.2DS and how this relates to the assessment and treatment of palatal abnormalities. Here is the abstract.
Research Presentations in 2014
University of Hong Kong Grand Rounds
Hong Kong, China
November 6th, 2014
At the University of Hong Kong Grand Rounds, Dr. Bassett presented the latest research on 22q11.2DS and the genetics of congenital cardiac disease.
22q11.2 Deletion Syndrome International Meeting
June 19, 2014
At this biennial international 22q11.2DS meeting, Dr. Bassett presented on antipsychotic treatment with clozapine in adults with 22q, and how to use a model of personalized care with patients.